Evidence map›Paper›PMID 27517945›Full record

ArticleInternational journal of environmental research and public health2016

PHACTR1 Gene Polymorphism Is Associated with Increased Risk of Developing Premature Coronary Artery Disease in Mexican Population.

Nonanzit Pérez-Hernández, Gilberto Vargas-Alarcón, Rosalinda Posadas-Sánchez, Nancy Martínez-Rodríguez, Carlos Alfonso Tovilla-Zárate, Adrián Asael Rodríguez-Cortés, Oscar Pérez-Méndez, Ruben Blachman-Braun, José Manuel Rodríguez-Pérez

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Journal of clinical medicine · 2022
    Article
  3. Review
  4. Article
  5. New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.Frontiers in bioscience (Landmark edition) · 2020
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Nonanzit Pérez-HernándezDepartment of Molecular Biology, National Institute of Cardiology "Ignacio Chávez", Juan Badiano No. 1, Col. Sección XVI, Tlalpan 14080, Mexico City, Mexico. unicanona@yahoo.com.mx.
Gilberto Vargas-AlarcónDepartment of Molecular Biology, National Institute of Cardiology "Ignacio Chávez", Juan Badiano No. 1, Col. Sección XVI, Tlalpan 14080, Mexico City, Mexico. gvargas63@yahoo.com.
Rosalinda Posadas-SánchezDepartment of Endocrinology, National Institute of Cardiology "Ignacio Chávez", Mexico City 14080, Mexico. rossy_posadas_s@yahoo.it.
Nancy Martínez-RodríguezCommunity Health Research Department, Children's Hospital of Mexico "Federico Gomez", Ministry of Health (SSA), Mexico City 06720, Mexico. amr70@hotmail.com.
Carlos Alfonso Tovilla-ZárateJuarez Autonomous University of Tabasco, Multidisciplinary Academic Division of Comacalco, Villahermosa 86040, Mexico. alfonso_tovillasz@yahoo.com.mx.
Adrián Asael Rodríguez-CortésDepartment of Molecular Biology, National Institute of Cardiology "Ignacio Chávez", Juan Badiano No. 1, Col. Sección XVI, Tlalpan 14080, Mexico City, Mexico. asaelrodriguezcortes@hotmail.com.
Oscar Pérez-MéndezDepartment of Molecular Biology, National Institute of Cardiology "Ignacio Chávez", Juan Badiano No. 1, Col. Sección XVI, Tlalpan 14080, Mexico City, Mexico. opmendez@yahoo.com.
Ruben Blachman-BraunDepartment of Molecular Biology, National Institute of Cardiology "Ignacio Chávez", Juan Badiano No. 1, Col. Sección XVI, Tlalpan 14080, Mexico City, Mexico. rubenblach@gmail.com.
José Manuel Rodríguez-PérezDepartment of Molecular Biology, National Institute of Cardiology "Ignacio Chávez", Juan Badiano No. 1, Col. Sección XVI, Tlalpan 14080, Mexico City, Mexico. josemanuel_rodriguezperez@yahoo.com.mx.
Instituto Nacional de Cardiología · MXHospital Infantil de México Federico Gómez · MXUniversidad Juárez Autónoma de Tabasco · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-nucleotide polymorphisms (SNPs) in the protein phosphatase and actin regulator 1 gene (PHACTR1) have been associated with susceptibility to develop several diseases, including cardiovascular disease. The purpose of this study was to evaluate the role of two polymorphisms (rs2026458 and rs9349379) of the PHACTR1 gene in the susceptibility to the risk of developing premature coronary artery disease (CAD) in the Mexican population. The genotype analysis was performed using 5'exonuclease TaqMan genotyping assays in a group of 994 patients with premature CAD and 703 controls. A similar genotype distribution of rs2026458 was observed in both groups; however, under an additive model adjusted by age, body mass index, type 2 diabetes mellitus, smoking, dyslipidemia, and hypertension, the rs9349379 G allele was associated with a higher risk for developing premature CAD (odds ratio (OR) = 1.22, 95% confidence interval (CI) = 1.03-1.46, p-value (p) = 0.024). The two PHACTR1 polymorphisms were not in linkage disequilibrium. In summary, our results suggest that the PHACTR1 rs9349379 polymorphism plays an important role in the risk of developing premature CAD in the Mexican population.

Indexed as

AdultAllelesCoronary Artery DiseaseDyslipidemiasFemaleGenetic Predisposition to DiseaseGenotypeHumansHypertensionMaleMexicoMicrofilament ProteinsMiddle AgedOdds RatioPolymorphism, Single NucleotideMicrofilament ProteinsPHACTR1 protein, humancoronary artery diseasegenetic polymorphismsPHACTR1 genevascular calcification

Identifiers

PMID27517945
PMCPMC4997489
OpenAlexW2513347119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.